CC
NEO icon

Chicago Capital’s NeoGenomics NEO Stock Holding History

Chicago Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,392
Closed -$171K – 371
2025
Q2 		$171K Sell
23,392
-615
-3% -$4.96K ﹤0.01% 349
2025
Q1 		$228K Buy
24,007
+7,627
+47% +$95.2K 0.01% 317
2024
Q4 		$270K Buy
+16,380
New +$254K 0.01% 283

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Chicago Capital's NEO Position: Q3 2025 in Review

Chicago Capital sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 23,392 shares — an estimated $171K sold.

Chicago Capital first reported a position in NEO in Q4 2024 and held it in 3 quarters. The position peaked at $270K in Q4 2024. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • Chicago Capital reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
  • Chicago Capital sold 23,392 NeoGenomics shares in Q3 2025, an estimated $171K.
  • Chicago Capital first reported a position in NeoGenomics in Q4 2024 and held it in 3 quarters.
  • Chicago Capital's NeoGenomics position peaked at $270K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Chicago Capital's 13F filing for Q3 2025, filed 22 Oct 2025.